Cargando…
Comparative study between Ribavirin and Ribavirin plus Intravenous Immunoglobulin against Crimean Congo hemorrhagic fever
BACKGROUND: Crimean Congo hemorrhagic fever (CCHF) has high morbidity and mortality. Therefore the treatment effect of Ribavirin with and without intravenous Immunoglobulin (IVIG) in viral Crimean Congo hemorrhagic fever was evaluated. MATERIALS AND METHODS: In a clinical trial study, 40 patients wi...
Autores principales: | Salehi, Hassan, Salehi, Marzieh, Adibi, Neda, Salehi, Maryam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818620/ https://www.ncbi.nlm.nih.gov/pubmed/24250699 |
Ejemplares similares
-
Ribavirin for treating Crimean Congo haemorrhagic fever
por: Johnson, Samuel, et al.
Publicado: (2018) -
Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis
por: Soares-Weiser, Karla, et al.
Publicado: (2010) -
Crimean-Congo Hemorrhagic Fever Beyond Ribavirin: A Systematic Review
por: Fabara, Stephanie P, et al.
Publicado: (2021) -
Ribavirin is not effective against Crimean–Congo hemorrhagic fever: observations from the Turkish experience()
por: Ceylan, Bahadır, et al.
Publicado: (2013) -
675. Crimean-Congo Hemorrhagic Fever Beyond Ribavirin: A Systematic Review
por: Fabara, Stephanie P, et al.
Publicado: (2021)